New two-session radiation approach aims to safely treat prostate cancer
NCT ID NCT05864196
First seen Feb 01, 2026 · Last updated May 05, 2026 · Updated 14 times
Summary
This study tests a new radiation therapy that delivers treatment in just two sessions, with a higher dose to the main tumor. It includes 80 men with low to intermediate risk prostate cancer. The goal is to see if this approach is safe and causes fewer side effects than standard longer treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NYCyberKnife at Perlmutter Cancer Center
RECRUITINGNew York, New York, 10016, United States
-
NYU Langone Hospital - Long Island
RECRUITINGMineola, New York, 11501, United States
Conditions
Explore the condition pages connected to this study.